Jang-ho Cha MD, PhD

Dr. Jang-Ho Cha, MD, PhD. has been appointed Chairman of the Board of Trustees at the Huntington’s Disease Society of America (HDSA). Dr. Cha is currently the Global Head of Translational Medicine, Neuroscience at Novartis. He obtained his M.D and Ph.D. from the University of Michigan and did his residency in neurology at Massachusetts General Hospital in Boston, MA. During his career at Massachusetts General Hospital at the New England HDSA Center of Excellence, Dr. Cha held multiple positions culminating in Associate Professor of Neurology.